Alpha 2.0
Login Register
» Authors » Christos Kiamouris

Christos Kiamouris

Explore the profile of Christos Kiamouris including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 82
Followers 0
Related Specialties
Oncology
Hematology
Urology
Top 10 Co-Authors
Meletios A Dimopoulos
George Fountzilas
Dimitra Gika
Chrisanthi Mitsouli
Ersi Voskaridou
Dimosthenis-Vasilios Skarlos
Aris Giannopoulos
Paris Kosmides
Athanasios Anagnostopoulos
Adamos Adamou
Published In
Urology
Leuk Lymphoma
J Clin Oncol
Haematologica
Lung Cancer
Affiliations
Soon will be listed here.
Recent Articles
1.
Zoledronic acid for the treatment of osteoporosis in patients with beta-thalassemia: results from a single-center, randomized, placebo-controlled trial
Voskaridou E, Anagnostopoulos A, Konstantopoulos K, Stoupa E, Spyropoulou E, Kiamouris C, et al.
Haematologica . 2006 Sep; 91(9):1193-202. PMID: 16956818
Background And Objectives: The aim of this study was to evaluate the effect of zoledronic acid (ZA) on thalassemia-induced osteoporosis. Design And Methods: We studied 66 thalassemia patients with osteoporosis,...
2.
The combination of estramustine, vinorelbine, and mitoxantrone in hormone-refractory prostate cancer: a Phase II feasibility study conducted by the Hellenic Cooperative Oncology Group
Samelis G, Kalofonos H, Adamou A, Kosmides P, Skarlos D, Aravantinos G, et al.
Urology . 2005 Aug; 66(2):382-5. PMID: 16098366
Objectives: To evaluate the safety profile and therapeutic value of the combination of estramustine, mitoxantrone, and vinorelbine in the treatment of hormone-refractory prostate cancer. Methods: Fifty-two patients with hormone-refractory prostate...
3.
Combination of LHRH analog with somatostatin analog and dexamethasone versus chemotherapy in hormone-refractory prostate cancer: a randomized phase II study
Dimopoulos M, Kiamouris C, Gika D, Deliveliotis C, Giannopoulos A, Zervas A, et al.
Urology . 2004 Jan; 63(1):120-5. PMID: 14751362
Objectives: To evaluate prospectively the combination of a luteinizing hormone-releasing hormone analog with a somatostatin analog and dexamethasone in patients with hormone-refractory prostate cancer (HRPC) in a randomized Phase II...
4.
Docetaxel and gemcitabine combination, as first-line treatment, in patients with extensive disease small-cell lung cancer. A phase II study of the Hellenic Cooperative Oncology Group
Skarlos D, Dimopoulos A, Kosmidis P, Papakostas P, Pavlidis N, Bacoyiannis C, et al.
Lung Cancer . 2003 Jun; 41(1):107-11. PMID: 12826319
There is some evidence that taxanes and gemcitabine are effective antitumor agents against small-cell lung cancer (SCLC). A total of 20 chemotherapy-naive patients with extensive disease (ED) SCLC, were treated...
5.
Treatment of Waldenström's macroglobulinemia with rituximab
Dimopoulos M, Zervas C, Zomas A, Kiamouris C, Viniou N, Grigoraki V, et al.
J Clin Oncol . 2002 May; 20(9):2327-33. PMID: 11981004
Purpose: Waldenström's macroglobulinemia (WM) is a low-grade lymphoplasmacytic lymphoma in which CD20 is usually expressed on tumor cells. There is evidence that patients with WM may benefit from treatment with...
6.
Primary treatment of low-grade non-Hodgkin's lymphoma with the combination of fludarabine and mitoxantrone: a phase II study of the Hellenic Cooperative Oncology Group
Dimopoulos M, Fountzilas G, Papageorgiou E, Kiamouris C, Mantzios G, Anagnostopoulos A, et al.
Leuk Lymphoma . 2002 Mar; 43(1):111-4. PMID: 11908713
The treatment of patients with recurrent low-grade lymphoma with the combination of fludarabine, mitoxantrone and dexamethasone has been associated with significant activity but has also caused frequent infectious complications. We...